Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

NCT03233711 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

344

Enrollment

NIH

Sponsor class

Conditions

Anal Basaloid Carcinoma
Anal Canal Cloacogenic Carcinoma
Anal Margin Squamous Cell Carcinoma
Stage IIB Anal Cancer AJCC v8
Stage III Anal Cancer AJCC v8

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Colonoscopy
PROCEDURE: Computed Tomography
PROCEDURE: Digital Rectal Examination
PROCEDURE: High Resolution Anoscopy
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
OTHER: Patient Observation
PROCEDURE: Proctoscopy
PROCEDURE: Sigmoidoscopy
PROCEDURE: X-Ray Imaging

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]